Tekmira Pharmaceuticals Corporation (TKMR) Stock Dives After EarningsMark Melin
Investors in Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) (TSE:TKM) might be greeted with a rude awakening Thursday morning, as the company missed its earnings estimates and badly whiffed on revenue. Shares of the stock were halted late in the afternoon pending the earnings announcement. In after hours trading, the stock is sharply lower, moving back to test support near the stock's 200 day moving average, which is currently at $15.87.
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.